微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.23% | 3.15% | 49.76% | 58/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.16% | 10.34% | 68.42% | 48/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.47% | -5.73% | -62.97% | 48/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 6.67% | -5.26% | 10.43% | 49/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.04% | -7.08% | 60.21% | 55/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.77% | 7.41% | 43.89% | 56/158 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.62% | -10.88% | -62.78% | 47/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 7.04% | 74.69% | 8.31% | 58/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 6.5% | 8.88% | 85.19% | 55/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.51% | -4.62% | 19.39% | 64/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.94% | 5.76% | -27.05% | 39/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.03% | 5657.14% | -32.5% | 83/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.97% | 41.47% | 62.23% | 67/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.68% | 42.08% | 32.37% | 70/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.78% | 21.4% | 3871.43% | 48/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.07% | -99.3% | -98.34% | 110/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.22% | -61.43% | 62.93% | 77/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.59% | -70.23% | 13.1% | 80/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.29% | -51.38% | -77.01% | 46/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 9.96% | -55.87% | -8.96% | 60/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.94% | -57.81% | 25.75% | 28/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 8.7% | -29.67% | 84.71% | 20/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.71% | -28.96% | -79.13% | 15/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 22.57% | -9.43% | -12.96% | 10/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 25.93% | 30.37% | 109.62% | 1/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 12.37% | -4.7% | 86.58% | 6/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 6.63% | -2.21% | -73.39% | 5/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 24.92% | -12.04% | 25.29% | 6/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 19.89% | -8.93% | 53.24% | 5/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 12.98% | -10.54% | 91.45% | 5/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 6.78% | -9.6% | -76.07% | 2/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 28.33% | -6.69% | 29.72% | 6/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 21.84% | -5.94% | 50.52% | 3/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 14.51% | -7.23% | 93.47% | 2/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 7.5% | -5.9% | -75.3% | 5/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 30.36% | -0.43% | 30.75% | 8/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 23.22% | 1.57% | 48.47% | 2/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 15.64% | 3.58% | 96.24% | 5/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 7.97% | 2.18% | -73.86% | 5/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 30.49% | 4.35% | 33.38% | 8/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 22.86% | 5.35% | 51.39% | 3/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 15.1% | 4.28% | 93.59% | 2/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 7.8% | 4.56% | -73.31% | 3/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |